Budesonide-incorporated inhalable lipid nanoparticles for antiTSLP nanobody mRNA delivery to treat steroid-resistant asthma

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-61114-4
Affiliations:
4
Authors:
5
Go to article
Institutions Authors Share
Shanghai Jiao Tong University (SJTU), China
3.000000
 0.60
New Jersey Institute of Technology (NJIT), United States of America (USA)
2.000000
 0.40
Interested in Immunology?